Europe | 14 October 2024 | News
In a candid conversation with Ankit Kankar from BioSpectrum Asia, Dr. Boro Dropulić, Executive Director of Car...Read more
Singapore | 02 October 2024 | Company results
Zuellig Pharma: A Sustainable Approach to Healthcare Access Through Innovative Solutions
The equitable distribution of medicines and their accessibility are critical to the resilience of the healthca...Read more
Bio Jobs | 01 October 2024 | Analysis
Biopharma Giants Face Industry-Wide Layoffs Amid Economic Pressures
The biopharmaceutical and healthcare industries, long seen as cornerstones of innovation, are currently grappl...Read more
Healthcare | 02 October 2024 | Analysis
How Alarming is Monkeypox threat perception?
Two years after the World Health Organization (WHO) declared a global health emergency over an Mpox outbreak, ...Read more
Clinical Trials | 02 October 2024 | Opinion
Can you elaborate on Medidata’s growth strategy for the APAC region? What specific factors are driving t...Read more
China | 26 September 2024 | News
Nuance Pharma expands distribution of nasal spray Bentrio in East and South East Asia
China-based Nuance Pharma has agreed with Altamira Medica, an associate company of Altamira Therapeutics ...Read more
Thailand | 23 September 2024 | News
Antengene receives approval to commercialise XPOVIO in Thailand for multiple myeloma patients
China-based Antengene Corporation has announced that the Thailand Food and Drug Administration has a...Read more
Japan | 05 September 2024 | News
US-based Rigel inks $162.5 M oncology deal with Kissei for Japan, Korea and Taiwan markets
US-based Rigel Pharmaceuticals, Inc., a commercial stage biotechnology company focused on hematologic disorder...Read more
China | 10 October 2024 | News
China-based CanSino Biologics Inc. has received an additional financial boost, securing a grant exceeding $17 ...Read more
China | 27 September 2024 | News
Bayer opens new life science incubator in Shanghai Innovation Park, China
German pharmaceutical company Bayer has announced the inauguration of its new life science incubator, Bayer Co...Read more
Singapore | 26 September 2024 | News
A landmark study led by Duke-NUS Medical School in Singapore has revealed that despite the recent pandemic, ou...Read more
Korea | 16 October 2024 | News
Korean firms Neurophet & AriBio to develop next-gen platform for Alzheimer's diagnosis
South Korea-based startup Neurophet, an artificial intelligence (AI) solution company for brain disease, has a...Read more
Indonesia | 10 October 2024 | News
Indonesia approves AI-assisted bone mineral density abnormalities screening software
Acer Medical, based in Taiwan, has announced that its artificial intelligence (AI)-assisted bone mineral densi...Read more
Taiwan | 26 September 2024 | News
Taiwan-based Flat Medical strengthens market leadership with acquisition of InjeQ assets
Taiwan-headquartered Flat Medical, a leading innovator in medical technology, has announced its acquisition of...Read more
Korea | 01 October 2024 | News
SK pharmteco invests $260 M in Korea facility to expand global small molecule and peptide production
US-headquartered SK pharmteco, a global contract development and manufacturing organisation (CDMO), has announ...Read more
Taiwan | 28 August 2024 | News
Taiwan-based Bora Pharmaceuticals Co. has announced that its Board of Directors has approved a strategic inves...Read more
Korea | 20 August 2024 | News
ST Pharm, a leading technology-driven RNA CDMO based in South Korea, and Belgium-based Quantoom Biosciences, a...Read more
How alarming is Monkeypox Threat Perception?
As the world finally emerges from the grip of COVID-19, a new threat looms: Mpox (formerly known as Monkeypox). In August 2024, the World Health Organisation (WHO) declared Mpox a global health emergency due to the rising cases of the new strain, clade I Mpox in Africa and Sweden, underscoring the urgent need for coordinated global action to monitor and contain the virus. As of September 2024, 2082 confirmed Mpox cases were reported globally, marking the highest number of monthly cases globally since November 2022. Nearly 400 cases have been reported in Asia Pacific this year.How are Asia Pacific countries stepping up surveillance measures and preparing their healthcare systems to combat Mpox? And just how significant is the threat posed by this outbreak? Let’s explore.
1 North Bridge Road,
#08-08 High Street Centre,
Singapore 179094
Email : communications@biospectrumasia.com
+65 90150305
